About Us
Our proprietary technologies
allow for the development of biostructures which are synthetic
biologically active tissue engineered products for the restoration
of the human skeleton. Industry analyst believes that Osteopore
International's core technology provides multiple opportunities
for growth through developing surgical implants and for
pursuing rapid regulatory approval for its products to initiate
near term revenue opportunities.
Clinical trials for the
tissue engineered product, which works by providing a scaffold
for the patient’s own bone cells to be regenerated,
have been successful. The research team is developing the
technology further to enable the scaffold to be implanted
in other parts of the body.
|